We are live on
!
Find out more
SC
Searle & Co Portfolio holdings
AUM
$398M
1-Year Est. Return
22.87%
This Fund
S&P 500
This Quarter
Est. Return
-0%
1 Year Est. Return
+22.87%
3 Year Est. Return
+66.45%
5 Year Est. Return
+103%
10 Year Est. Return
+295.26%
AUM
$347M
AUM Growth
-$54.1M
(-13%)
Cap. Flow
-$55.5M
Cap. Flow
% of AUM
-16.01%
Top 10 Holdings %
Top 10 Hldgs %
34.84%
Holding
186
New
15
Increased
37
Reduced
35
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$4.34M |
| 2 |
CSX Corp
CSX
|
+$1.29M |
| 3 |
Merck
MRK
|
+$1.29M |
| 4 |
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
|
+$784K |
| 5 |
PepsiCo
PEP
|
+$743K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$67M |
| 2 |
Cintas
CTAS
|
+$1.48M |
| 3 |
Yum! Brands
YUM
|
+$887K |
| 4 |
Bunge Global
BG
|
+$290K |
| 5 |
Adobe
ADBE
|
+$220K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.67% |
| 2 | Healthcare | 13.49% |
| 3 | Financials | 13.43% |
| 4 | Industrials | 12.57% |
| 5 | Consumer Staples | 9.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Reddit
RDDT
$35B
| $381K | 0.11% |
+2,333
| New | +$288K |
|
127
Quest Diagnostics
DGX
$23B
| $377K | 0.11% |
2,500
| – | – |
|
128
MetLife
MET
$59.8B
| $373K | 0.11% |
4,560
| – | – |
|
129
Sony
SONY
$124B
| $366K | 0.11% |
17,300
| – | – |
|
130
Clorox
CLX
$11.6B
| $365K | 0.11% |
2,246
| – | – |
|
131
Thermo Fisher Scientific
TMO
$196B
| $356K | 0.1% |
685
| – | – |
|
132
Blackstone
BX
$151B
| $345K | 0.1% |
2,000
| – | – |
|
133
CenterPoint Energy
CNP
$28.1B
| $328K | 0.09% |
10,334
| – | – |
|
134
State Street Energy Select Sector SPDR ETF
XLE
$38.4B
| $327K | 0.09% |
7,636
| – | – |
|
135
iShares MSCI EAFE ETF
EFA
$75.8B
| $323K | 0.09% |
4,269
| – | – |
|
136
Cheniere Energy
CQP
$30.9B
| $319K | 0.09% |
6,000
| – | – |
|
137
L3Harris
LHX
$52.3B
| $315K | 0.09% |
1,500
| – | – |
|
138
Target
TGT
$63.4B
| $311K | 0.09% |
2,300
| – | – |
|
139
Paychex
PAYX
$41B
| $308K | 0.09% |
2,200
| – | – |
|
140
Brookfield Asset Management
BAM
$75.6B
| $307K | 0.09% |
5,662
| – | – |
|
141
Trane Technologies
TT
$103B
| $295K | 0.09% |
800
| – | – |
|
142
GE Vernova
GEV
$290B
| $295K | 0.09% |
896
-62
| -6% | -$19.4K |
|
143
Marathon Petroleum
MPC
$92.1B
| $293K | 0.08% |
2,098
| – | – |
|
144
Lowe's Companies
LOW
$115B
| $292K | 0.08% |
1,182
| – | – |
|
145
Netflix
NFLX
$285B
| $285K | 0.08% |
3,200
| – | – |
|
146
FirstEnergy
FE
$28.1B
| $283K | 0.08% |
7,121
| – | – |
|
147
Genuine Parts
GPC
$16.8B
| $281K | 0.08% |
2,409
-267
| -10% | -$33.3K |
|
148
Halliburton
HAL
$29.3B
| $279K | 0.08% |
10,249
| – | – |
|
149
Comcast
CMCSA
$84.9B
| $276K | 0.08% |
7,360
+230
| +3% | +$9.55K |
|
150
Lockheed Martin
LMT
$117B
| $273K | 0.08% |
562
+12
| +2% | +$6.54K |
|
Similar funds
CF
VC
DL
ECA
BWM
MHC
LSA
THL
Searle & Co's Q4 2024 Portfolio in Review
As of Q4 2024, Searle & Co held 186 positions worth $347M, down 13% from $401M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Searle & Co withdrew a net $55.5M in Q4 2024, closing 9 positions and reducing 35 holdings. Its most notable exit was Cintas, an estimated $1.48M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Searle & Co opened a new position in Berkshire Hathaway Class B worth $4.26M.
- Searle & Co's largest Q4 2024 buy was Berkshire Hathaway Class B: 9,389 shares worth $4.26M.
- Searle & Co added most to Merck in Q4 2024, an estimated $1.29M increase.
- Searle & Co's biggest Q4 2024 reduction was JPMorgan Chase, cutting an estimated $67M.
- Searle & Co fully exited Cintas in Q4 2024, selling an estimated $1.48M.
- Searle & Co's ten largest holdings make up 35% of its $347M portfolio in Q4 2024.
- Searle & Co opened 15 new positions and closed 9 in Q4 2024.
- Searle & Co's portfolio value fell 13% quarter-over-quarter to $347M.
Based on Searle & Co's 13F filing for Q4 2024, filed 14 Feb 2025.